What's next for AppliedVR after its FDA De Novo

Cofounder and CEO Matthew Stoudt discusses AppliedVR's De Novo clearance from November, what's next for the company and the biggest trends from 2021.

from MobiHealthNews https://ift.tt/3tLwrHU
https://ift.tt/eA8V8J